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Abstract—Pelargonium graveolens (Geranium) is a source of 
finest quality of fragrance and its essential oils (EOs) are used as 
antibacterial and antifungal agent. The aim of the current research 
is to determine chemical constituents in EO of P. graveolens by 
gas chromatography–mass spectrometry (GC–MS) and evaluate 
its antidiabetic activity through α-glucosidase inhibition assay. 
The chemical composition of P. graveolens EO was determined 
by GC/MS and its antidiabetic activity was assessed through 
inhibition of α-glucosidase enzyme in in vitro models. GC–MS 
analysis determines 36 chemical components in the EO of 
P. graveolens leaves, and citronellyl isovalerate (10.41%), menthol 
(9.61%), linalool (8.63%), p-menthone (6.31%), and geranyl 
tiglate (4.99%) were recorded as major constituents. The EO of 
P. graveolens leaves showed concentration-dependent inhibition of 
α-glucosidase enzyme ranging from 28.13 ± 1.41 to 74.24 ± 2.53% for 
concentration ranging from 31.25 to 1000 µg/mL, respectively. The 
IC50 values for of P. graveolens and acarbose were found as 93.72 ± 
4.76 and 80.4 ± 2.17 µg/mL, respectively, against the α-glucosidase 
enzyme. The study finding explores the chemical components of 
P. graveolens growing in Iraqi Kurdistan region and scientifically 
supported its possible use in diabetic patients for controlling 
postprandial hyperglycemia.
Index Terms—Pelargonium graveolens, Geranium, Geraniaceae, 
Diabetes, Gas chromatography–mass spectrometry, α-Glucosidase 
enzyme.
I. Introduction
Medicinal plants have emerged as major source drugs for the 
treatment of chronic diseases such as cancer, diabetes, and 
cardiovascular complications. Natural products derived from 
medicinal plants are considered safe and effective compared 
to synthetic modern drugs based on the long history of use 
by humans as food and medicine (Ahamad, et al., 2019). 
Diabetes is a chronic disorder of metabolism caused by an 
absolute or relative lack of insulin and characterized by 
hyperglycemia, glycosuria, and hyperlipidemia (Gin and 
Rigalleau, 2000). The number of people in the world with 
diabetes has increased dramatically over recent years. Post-
prandial hyperglycemia (PPHG) is one of the key risk factors 
associated with diabetes. PPHG results due to the fast uptake 
of glucose in the intestine under the influence of hydrolyzing 
enzymes α-amylase and α-glucosidase that change 
polysaccharides through oligosaccharides to monosaccharides 
(Subramanian, Asmawi and Sadikun, 2008). Inhibition of 
α-amylase and α-glucosidase enzymes leads to a reduction 
in their hydrolysis and thereby controlled blood glucose 
levels (Dong, Li, Zhu, Liu and Huang, 2012). Therefore, an 
important strategy for managing PPHG is to inhibit α-amylase 
and α-glucosidase enzymes (Scheen, 2003). The α-amylase 
and α-glucosidase enzyme inhibitors as therapeutic agents 
are being increasingly pursued. These enzymes are preferred 
targets for the management of PPHG particularly in pre-
diabetics or those with impaired glucose tolerance (Ahamad, 
Naquvi, Mir and Ali, 2011). Natural products as α-amylase 
and α-glucosidase inhibitors have attracted considerable 
interest in the drug discovery endeavors (Ahamad, Hasan, 
Amin and Mir, et al., 2016; Ahamad, Alkefai, Amin and Mir, 
2020; Alkefai, Ahamad, Amin and Mir, et al., 2018; Alkefai, 
Ahamad, Amin and Mir, 2018). The clinically used inhibitors 
of carbohydrate metabolizing enzymes such as acarbose, 
voglibose, and miglitol are non-specific in their action. This 
results in side effects such as flatulence and distension caused 
due to bacterial fermentation of undigested carbohydrates. 
Thus, the search for selective inhibitors of these enzymes 
is still on and more and more medicinal plants are being 
screened continuously. Screening of traditionally used plants 
for the drug discovery process is often advocated as the 
chances of success using this approach are more (Fabricant 
and Farnsworth, 2001).
Pelargonium genus belonging to the family Geraniaceae 
and contains about 250 species (such as Pelargonium 
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graveolens, Pelargonium capitatum, Pelargonium zonale, 
Pelargonium roseum, and Pelargonium odoratissimum). 
Pelargonium is distributed throughout Mediterranean region 
but most profoundly present in South Africa (Miller, 2002). 
P. graveolens is a source of high-quality essential oil (EO) 
that is rich in citronellol and geraniol. P. graveolens EO is 
commonly known as geranium oil and is extensively used 
as perfumes and in skin care products. P. graveolens EO 
is also used in aromatherapy, and pharmacologically, it acts 
as antibacterial, antifungal, insect repellent, and has skin 
cleansing properties (Pattnaik, Subramanyam and Kole, 
1996; Pattnaik, Subramanyam, Bapaji and Kole, 1997; 
Rao Rajeswara, Kaul, Mallavarapu and Ramesh, 1996; 
Lis-Balchin, Buchbauer, Ribisch and Wenger, 1998; Lis-
Balchin, Steyrl and Krenn, 2003). In the present research 
work, an attempt has been made to determine the chemical 
composition of EO from leaves of P. graveolens by gas 
chromatography–mass spectrometry (GC–MS). The present 
study was also designed to evaluate its antidiabetic activity 
through inhibition of α-glucosidase enzyme.
II. Materials and Methods
A. Plant Materials and Chemicals
The fresh leaves of P. graveolens (500 g) were collected 
in the month of March 2020 from local market of Erbil, 
Kurdistan Region, Iraq. The authenticity of all the accession 
was ascertained by Taxonomist. The plant sample was 
kept in the Faculty of Pharmacy, Tishk International 
University, Erbil, Iraq. For future reference (voucher number: 
PRL/2020/07), p-Nitrophenyl-α-D-glucopyranoside (PNPG), 
3,5-dinitrosalicylic acid (DNS), acarbose, and α-glucosidase 
enzyme were brought from Subra Scientific Company, 
Chennai, India. All other solvents and chemicals used in the 
study were of analytical grade
B. Isolation of EO from Leaves of P. graveolens
The fresh P. graveolens leaves (500 g) were hydrodistilled 
for 6 h in Clevenger apparatus. After isolation of EO, the 
volatile oil was collected in the graduated tube and dried over 
anhydrous sodium sulfate and stored at 4°C in a refrigerator 
for further use.
C. GC–MS Analysis and Identification of Chemical 
Constituents
The chemical composition of P. graveolens EO was 
determined by the GC–MS method. Agilent Bench 
Top GC–MS (Agilent Technologies, Wilmington, DE, 
USA) equipment with a capillary column of DB-5 glass 
(specifications 30 m × 2.5 mm i.d; film thickness of 0.25 µm) 
was applied for test sample analysis. Helium was used as 
carrier gas at flow rate of 1 mL/min. The oven temperature 
was set at 50°C for 1 min and then holds isothermally 
for 2 min at 320°C. The temperature of injector port was 
maintained at 250°C, and ion source temperature was kept 
at 200°C, and interface temperature was maintained at 
300°C. The EO (1 µL) was injected and the split ratio was 
kept at 1:5. Data capture took place at 70 eV using scanning 
times of 1.5 s in the mass range of 50–1000 amu and run 
time was kept up to 38 min. The chromatography and mass 
spectra were handled with ChemStation software (Agilent 
Technologies, Wilmington, DE, USA).
The individual peaks/constituents were identified by 
comparison of their Kovats index (K.I.) with those of 
literature in close agreement to K.I. Further identification 
of EO constituents was made by comparison of the 
fragmentation pattern of mass spectra obtained by GC/
MS analysis with those stored in the spectrometer database 
of NIST, NBS 54 K.L, WILEY8 libraries, and published 
literature (Adams, 2007; Ali, 2001; Rana, et al., 2002; 
Bhattacharya, Kaul, Rao, Ramesh and Mallavarapu, 1993; 
Abd El-Kareem, Rabbih, Elansary and Al-Mana, 2020). The 
percent composition of the EO compounds was calculated. 
The qualitative analysis was based on the percent area of 
each peak of the sample compounds.
D. In vitro α-Glucosidase Inhibitory Activity
Antidiabetic activity of EO of P. graveolens was 
assessed through α-glucosidase inhibition assay. The 
assay method briefly summarized as 60 µL of EO of 
P. graveolens in DMSO with concentrations ranging from 
31.25 to 1000 µg/mL and 0.1 M phosphate buffer (50 mL; 
pH 6.8) containing α-glucosidase solution (0.2 U/mL) was 
incubated at 37°C for 20 min in 96-well plates. PNPG 
(50 mL; 5 mM) solution in a 0.1 M phosphate buffer 
(pH 6.8) was applied to each well after pre-incubation 
and further incubated for 20 min at 37°C. Then, the 
reaction was stopped by adding 160 mL of 0.2 M NaCO3 
into each well. Absorbance (A) was reported at 405 nm 
with microplate reader and compared to a control which 
had 60 µL of buffer solution in place of the test sample. 
Acarbose was used as a standard drug and evaluated same 
way as the test sample (Ahamad, Alkefai, Amin and Mir, 
2020). The % inhibition of α-glucosidase enzyme was 
calculated using the following formula:
Abs control Abs % 100
Abs control
testInhibition −= ×
where, Abs is absorbance of the control and absorbance of 
the sample
III. Results and Discussion
A. GC–MS Analysis of EO of P. graveolens
The EO from leaves of P. graveolens was isolated by 
the hydrodistillation method. The hydrodistillation yielded 
0.45% of EO from leaves of P. graveolens. The chemical 
composition of EO of P. graveolens was determined by 
the GC–MS method and results are presented in Table 
I and Fig. 1. Thirty-six components representing 99.17% 
of the total detected constituent were identified. The 
major constituents in the EO of P. graveolens include 
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Fig. 1. Gas chromatography–mass spectrometry chromatogram of essential oil of Pelargonium graveolens.
citronellyl isovalerate (10.41%), menthol (9.61%), linalool 
(8.63%), p-menthone (6.31%), geranyl tiglate (4.99%), 
neryl propionate (4.79%), isocaryophyllene (3.77%), and 
caryophyllene epoxide (3.63%). The other components 
of P. graveolens EOs are geranyl butyrate (3.50%), 
neryl hexanoate (2.98%), geranyl heptanoate (2.93%), 
heptaminol (2.92%), citronellyl hexanoate (2.64%), 
neryl acetate (2.32%), myrtanol (2.23%), citronellol 
(2.22%), and nerolidyl acetate (2.18%). Other minor 
chemical components (<2%) of EO of P. graveolens are 
also presented in Table I. Rana, et al. studied the EO 
composition of P. graveolens leaves from Uttarakhand, 
India. The results show that citronellol (33.6%), geraniol 
(26.8%), linalool (10.5%), citronellyl formate (9.7%), 
and p-menthone (6.0%) were major chemical components 
in EO (Rana, et al., 2002). Bhattacharya, et al. (1993) 
studied volatile oil components of rose-scented Geranium 
and found that citronellol (25.44%), geraniol (21.87%), 
and linalool (7.87%) as major chemical compounds. In 
another study, EO components of P. graveolens from 
Egypt were studied by GC–MS. The study also shows 
citronellol (27.67%), cis-Menthone (10.23%), linalool 
(10.05%), eudesmol (9.40%), geraniol formate 6.87%, 
and rose oxide (5.77%) as major constituents (Abd El-
Kareem, Rabbih, Elansary and Al-Mana, 2020). The 
present research is the first study on EO composition of 
Geranium growing in Iraqi Kurdistan. The study shows 
the presence of derivatives of citronellyl and geraniol, the 
major components already reported by other researchers 
such as citronellyl isovalerate (10.41%) and geranyl tiglate 
(4.99%). The present study finding is also comparable 
with the previous findings as study shows the presence 
of menthol (9.61%), linalool (8.63%), and p-menthone 
(6.31%) as other major components. The variation in 
the chemical composition of Geranium is maybe due to 
variations in geographical location, temperature, rainfall, 
soil, etc. (Ahamad, Uthirapathy, Ameen and Anwer, 2019).
B. α-Glucosidase Inhibition Activity of EO of P. graveolens
The EO of P. graveolens showed concentration-dependent 
α-glucosidase enzyme inhibition that varies from 28.13 ± 
1.41 to 74.24 ± 2.53% for concentration ranging from 31.25 
to 1000 µg/mL (Table II and Fig. 2). Acarbose was used as 
positive standard and it also showed concentration-dependent 
inhibition of α-glucosidase enzyme inhibition ranging from 
31.94 ± 2.45 to 81.26 ± 3.21% for the same concentration 
as test sample above. The IC50 values for P. graveolens and 
acarbose were found as 93.72 ± 4.76 and 80.4 ± 2.17 µg/mL, 
respectively, against α-glucosidase enzyme.
The results of enzyme inhibition assay indicate that the EO 
of P. graveolens inhibits α-glucosidase enzyme in in vitro 
study. The results also show that the EO of P. graveolens 
was found comparable with standard acarbose in inhibition 
of α-glucosidase enzyme. α-Amylase and α-glucosidase 
enzymes are present in brush border of gastrointestinal 
tract and responsible for breakdown of polysaccharides and 
disaccharides, respectively. Inhibition of these enzymes leads 
reduction of monosaccharides available for absorption in 
blood and ultimately it controls sudden rise of blood glucose 
level after meals. The increased blood sugar level after 
a meal is known as PPHG and controlling it by inhibiting 
α-glucosidase enzyme is a new strategy in management 
of type 2 diabetes. The inhibitors of α-amylase and 
α-glucosidase enzymes such as acarbose and miglitol are non-
specific in their action, the strong inhibition of both enzymes 
leads decreased metabolism of polysaccharides which causes 
ARO p-ISSN: 2410-9355, e-ISSN: 2307-549X 
112 http://dx.doi.org/10.14500/aro.10791
IV. conclusion
GC–MS analysis of Kurdish P. graveolens EO yielded 
citronellyl isovalerate, menthol, linalool, p-menthone, and 
geranyl tiglate as major constituents. P. graveolens EO also 
found potent inhibitors of α-glucosidase enzyme. The current 
research is first reports on the chemical composition of 
P. graveolens growing in Iraqi Kurdistan region. The findings 
of the present study also provide a scientific basis for its use 
in diabetic patients for controlling PPHG.
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antidiabetic effects of P. graveolens EO in controlling PPHG 
through inhibition of α-glucosidase enzyme.
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